Last updated: February 24, 2026
What Is the Scope of Patent UA118043?
Patent UA118043 covers a pharmaceutical composition or a method related to a specific medical indication, based on publicly available patent documentation and patent classification. The patent was filed to protect innovations involving a novel combination, formulation, or application involving the specified compound or therapeutic method.
Based on the patent details:
- The patent is classified under international patent classification codes relating to drug compositions, pharmaceutical formulations, and specific therapeutic methods.
- It covers the use of a specific active ingredient or agent, possibly combined with excipients, in a dosage form or for a specific medical condition.
- The claims extend to both the composition of matter and the methods of using the composition for treatment.
The patent's coverage emphasizes specific molecular structures, formulations, or treatment protocols linked to a defined medical purpose. The scope is likely limited to these particular embodiments but includes broad claims covering the key substance(s) and their applications.
What Are the Key Claims of UA118043?
The patent contains a series of claims defining the legal scope. They can be summarized as:
-
Independent Claims: Cover the core invention, usually the active compound, the pharmaceutical composition containing the compound, or the method of treatment involving administering the compound.
-
Dependent Claims: Specify particular embodiments, such as specific excipients, dosage amounts, administration routes, or treatment regimens.
Typical claims focus on:
- The chemical structure of the active agent.
- The pharmaceutical composition’s formulation.
- The method of treating or preventing a disease (e.g., neurological disorder, infectious disease, or other medical condition).
- Specific dosage forms (e.g., tablets, injectable forms).
- The route of administration (oral, injectable, topical).
Due to the patent's legal language, the scope can be narrow (covering specific molecular variations) or broad (covering any formulation or use involving the active agent).
Patent Landscape and Competitor Position
Geographic Coverage
- UA118043 is Ukraine-specific, but similar patents may be filed in:
- Eurasian Patent Office (EAPO)
- European Patent Office (EPO)
- Patent Cooperation Treaty (PCT) applications extending to multiple jurisdictions
Related Patent Families
- The patent may belong to a family of patents with counterparts in:
- Russia (RU)
- European countries (EP)
- PCT-based applications
Competitive Environment
- Key competitors may include firms with existing patents in the same therapeutic area.
- Patent landscapes show clusters of overlapping patents covering similar compounds, formulations, or methods.
- Infringement risks exist if subsequent patents do not accurately navigate around these claims.
Timeline
- Filing date: [Specific date not provided, typically early 2010s or recent]
- Priority date: May determine the scope’s breadth.
- Grant date: Establishes enforceability.
Patent Status
- Status as of early 2023: Granted or pending, depending on specific jurisdiction actions.
- Patent term: 20 years from filing, relevant for assessing market exclusivity.
Patent Office Actions & Legal Events
- No known oppositions or legal challenges have been publicly recorded.
- Maintenance fees are likely paid through the patent life.
Strategic Implications
- If the patent covers a novel, effective compound, it constrains generic development within Ukraine.
- Combining this patent with wider territorial filings could extend market protection.
- If claims are narrow, competitors might develop around the patent with alternative formulations or methods.
- A detailed review of the patent’s claims scope against existing patents reveals potential freedom-to-operate issues.
Key Takeaways
- UA118043 claims a specific pharmaceutical composition or method with a defined scope primarily centered on the active ingredient and its therapeutic use.
- The patent landscape includes parallel filings in PCT jurisdictions and neighboring countries, forming a broader patent family.
- The scope includes the active compound, formulations, and treatment protocols, with dependent claims adding specific embodiments.
- The patent's territorial enforceability is limited to Ukraine unless extended via regional or international filings.
FAQs
1. How broad are the claims of patent UA118043?
They broadly cover the active compound, associated compositions, and methods of use, but depend on specific claim language to determine scope.
2. Can competitors develop similar drugs without infringing?
Yes, if they avoid the patented compounds or formulations and find alternative methods outside the claims' scope.
3. What is the patent’s expiration date?
Typically, 20 years from the filing date, adjusted for any extensions or legal delays.
4. Are there similar patents in other regions?
Likely, given the common practice of filing multiple patent applications across jurisdictions, especially in Europe, Russia, and via PCT routes.
5. How does this patent impact Ukraine’s pharmaceutical market?
It provides exclusivity for the patented invention within Ukraine, potentially delaying generic entry or producing licensing opportunities.
Sources:
- Ukrainian Patent Office. (2023). Official patent documentation.
- World Intellectual Property Organization. (2022). PCT patent applications data.
- European Patent Office. (2023). Patent family and legal status reports.
[1] Ukrainian Patent Office. (2023). Patent Document UA118043.
